Literature DB >> 4142995

Letter: Propranolol and pregnancy.

G I Fiddler.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1974        PMID: 4142995     DOI: 10.1016/s0140-6736(74)93301-7

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  7 in total

Review 1.  Comparative risk-benefit assessment of drugs used in the management of hypertension in pregnancy.

Authors:  P M Kyle; C W Redman
Journal:  Drug Saf       Date:  1992 May-Jun       Impact factor: 5.606

2.  Neonatal effects of maternal administration of acebutolol.

Authors:  Y Dumez; C Tchobroutsky; H Hornych; C Amiel-Tison
Journal:  Br Med J (Clin Res Ed)       Date:  1981-10-24

3.  Pharmacokinetics of propranolol during pregnancy.

Authors:  M F O'Hare; C D Kinney; G A Murnaghan; D G McDevitt
Journal:  Eur J Clin Pharmacol       Date:  1984       Impact factor: 2.953

4.  Randomised comparison of methyldopa and oxprenolol for treatment of hypertension in pregnancy.

Authors:  E D Gallery; D M Saunders; S N Hunyor; A Z Györy
Journal:  Br Med J       Date:  1979-06-16

5.  Effect of propranolol treatment in pregnant rats on motor activity and avoidance learning of the offspring.

Authors:  Z Speiser; A Shved; S Gitter
Journal:  Psychopharmacology (Berl)       Date:  1983       Impact factor: 4.530

6.  First year of life after the use of atenolol in pregnancy associated hypertension.

Authors:  B Reynolds; L Butters; J Evans; T Adams; P C Rubin
Journal:  Arch Dis Child       Date:  1984-11       Impact factor: 3.791

Review 7.  The Risk for Neonatal Hypoglycemia and Bradycardia after Beta-Blocker Use during Pregnancy or Lactation: A Systematic Review and Meta-Analysis.

Authors:  Rosalie de Bruin; Sarah L van Dalen; Shamaya J Franx; Viraraghavan V Ramaswamy; Sinno H P Simons; Robert B Flint; Gerbrich E van den Bosch
Journal:  Int J Environ Res Public Health       Date:  2022-08-04       Impact factor: 4.614

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.